Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for ELF2_GABPA_ELF5
Z-value: 0.30
Motif logo
Transcription factors associated with ELF2_GABPA_ELF5
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ELF2
|
ENSG00000109381.15 | E74 like ETS transcription factor 2 |
|
GABPA
|
ENSG00000154727.6 | GA binding protein transcription factor subunit alpha |
|
ELF5
|
ENSG00000135374.5 | E74 like ETS transcription factor 5 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ELF5 | hg19_v2_chr11_-_34535297_34535317 | -0.41 | 1.8e-02 | Click! |
| GABPA | hg19_v2_chr21_+_27107672_27107698 | 0.36 | 4.0e-02 | Click! |
| ELF2 | hg19_v2_chr4_-_140005443_140005650 | 0.16 | 3.9e-01 | Click! |
Activity profile of ELF2_GABPA_ELF5 motif
Sorted Z-values of ELF2_GABPA_ELF5 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51875894 | 22.02 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
| chr11_-_61129723 | 14.90 |
ENST00000537680.1
ENST00000426130.2 ENST00000294072.4 |
CYB561A3
|
cytochrome b561 family, member A3 |
| chr11_-_118122996 | 14.28 |
ENST00000525386.1
ENST00000527472.1 ENST00000278949.4 |
MPZL3
|
myelin protein zero-like 3 |
| chr12_+_69742121 | 14.08 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
| chr11_-_61129335 | 12.76 |
ENST00000545361.1
ENST00000539128.1 ENST00000546151.1 ENST00000447532.2 |
CYB561A3
|
cytochrome b561 family, member A3 |
| chr1_-_161039456 | 11.90 |
ENST00000368016.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr19_-_51875523 | 11.20 |
ENST00000593572.1
ENST00000595157.1 |
NKG7
|
natural killer cell group 7 sequence |
| chr4_-_74847800 | 11.16 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
| chr19_-_10450287 | 11.14 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
| chr11_-_118083600 | 11.10 |
ENST00000524477.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chr11_+_118175132 | 11.06 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr1_+_153330322 | 11.05 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
| chr3_+_52321827 | 10.78 |
ENST00000473032.1
ENST00000305690.8 ENST00000354773.4 ENST00000471180.1 ENST00000436784.2 |
GLYCTK
|
glycerate kinase |
| chr11_-_61129306 | 10.39 |
ENST00000544118.1
|
CYB561A3
|
cytochrome b561 family, member A3 |
| chr7_+_50348268 | 10.06 |
ENST00000438033.1
ENST00000439701.1 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
| chr14_-_23299009 | 10.04 |
ENST00000488800.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr19_+_42381173 | 9.97 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr20_+_43104541 | 9.94 |
ENST00000372906.2
ENST00000456317.1 |
TTPAL
|
tocopherol (alpha) transfer protein-like |
| chrY_+_2709906 | 9.88 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
| chr21_-_46340884 | 9.75 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr2_+_218990727 | 9.67 |
ENST00000318507.2
ENST00000454148.1 |
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr15_+_74833518 | 9.67 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
| chr17_+_57784997 | 9.52 |
ENST00000537567.1
ENST00000539763.1 ENST00000587945.1 ENST00000536180.1 ENST00000589823.2 ENST00000592106.1 ENST00000591315.1 ENST00000545362.1 |
VMP1
|
vacuole membrane protein 1 |
| chr9_-_115095851 | 9.51 |
ENST00000343327.2
|
PTBP3
|
polypyrimidine tract binding protein 3 |
| chr11_+_61129456 | 9.34 |
ENST00000278826.6
|
TMEM138
|
transmembrane protein 138 |
| chr12_-_10151773 | 9.20 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
| chr19_+_42381337 | 9.12 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr16_+_57702210 | 9.11 |
ENST00000450388.3
|
GPR97
|
G protein-coupled receptor 97 |
| chr1_-_52499443 | 9.06 |
ENST00000371614.1
|
KTI12
|
KTI12 homolog, chromatin associated (S. cerevisiae) |
| chr14_+_22475742 | 9.06 |
ENST00000390447.3
|
TRAV19
|
T cell receptor alpha variable 19 |
| chr12_-_498620 | 8.84 |
ENST00000399788.2
ENST00000382815.4 |
KDM5A
|
lysine (K)-specific demethylase 5A |
| chr20_+_43104508 | 8.78 |
ENST00000262605.4
ENST00000372904.3 |
TTPAL
|
tocopherol (alpha) transfer protein-like |
| chr1_-_153518270 | 8.77 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
| chr12_-_498415 | 8.72 |
ENST00000535014.1
ENST00000543507.1 ENST00000544760.1 |
KDM5A
|
lysine (K)-specific demethylase 5A |
| chr4_+_74718906 | 8.67 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
| chr1_+_93811438 | 8.54 |
ENST00000370272.4
ENST00000370267.1 |
DR1
|
down-regulator of transcription 1, TBP-binding (negative cofactor 2) |
| chr1_-_36937075 | 8.52 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
| chr1_-_32687923 | 8.49 |
ENST00000309777.6
ENST00000344461.3 ENST00000373593.1 ENST00000545122.1 |
TMEM234
|
transmembrane protein 234 |
| chr16_-_3306587 | 8.40 |
ENST00000541159.1
ENST00000536379.1 ENST00000219596.1 ENST00000339854.4 |
MEFV
|
Mediterranean fever |
| chr16_+_29674277 | 8.39 |
ENST00000395389.2
|
SPN
|
sialophorin |
| chr14_+_21249200 | 8.37 |
ENST00000304677.2
|
RNASE6
|
ribonuclease, RNase A family, k6 |
| chr3_+_122296443 | 8.37 |
ENST00000464300.2
|
PARP15
|
poly (ADP-ribose) polymerase family, member 15 |
| chr19_-_56632592 | 8.35 |
ENST00000587279.1
ENST00000270459.3 |
ZNF787
|
zinc finger protein 787 |
| chr5_-_180237445 | 8.34 |
ENST00000393340.3
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr21_-_46340807 | 8.34 |
ENST00000397846.3
ENST00000524251.1 ENST00000522688.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr10_-_72362515 | 8.28 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
| chr1_+_32687971 | 8.28 |
ENST00000373586.1
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I |
| chr19_-_54804173 | 8.25 |
ENST00000391744.3
ENST00000251390.3 |
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 |
| chr15_-_64648273 | 8.19 |
ENST00000607537.1
ENST00000303052.7 ENST00000303032.6 |
CSNK1G1
|
casein kinase 1, gamma 1 |
| chr3_+_47324424 | 8.12 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
| chr12_-_6798616 | 8.10 |
ENST00000355772.4
ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384
|
zinc finger protein 384 |
| chr9_-_139927462 | 8.09 |
ENST00000314412.6
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
| chrX_+_64808248 | 8.08 |
ENST00000609672.1
|
MSN
|
moesin |
| chrX_-_153775426 | 8.06 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr12_-_6798523 | 8.06 |
ENST00000319770.3
|
ZNF384
|
zinc finger protein 384 |
| chr9_-_115095883 | 8.03 |
ENST00000450374.1
ENST00000374255.2 ENST00000334318.6 ENST00000374257.1 |
PTBP3
|
polypyrimidine tract binding protein 3 |
| chr17_-_62009621 | 7.97 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chr19_+_7701985 | 7.97 |
ENST00000595950.1
ENST00000441779.2 ENST00000221283.5 ENST00000414284.2 |
STXBP2
|
syntaxin binding protein 2 |
| chr10_-_12238071 | 7.96 |
ENST00000491614.1
ENST00000537776.1 |
NUDT5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
| chr2_-_219031709 | 7.93 |
ENST00000295683.2
|
CXCR1
|
chemokine (C-X-C motif) receptor 1 |
| chr19_+_51645556 | 7.92 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
| chr11_+_67171548 | 7.90 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr2_+_98330009 | 7.86 |
ENST00000264972.5
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa |
| chr22_-_37880543 | 7.85 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr20_+_49575342 | 7.79 |
ENST00000244051.1
|
MOCS3
|
molybdenum cofactor synthesis 3 |
| chr16_-_68034470 | 7.79 |
ENST00000412757.2
|
DPEP2
|
dipeptidase 2 |
| chr17_+_45331184 | 7.77 |
ENST00000559488.1
ENST00000571680.1 ENST00000435993.2 |
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
| chr19_-_10446449 | 7.76 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr16_+_57702099 | 7.73 |
ENST00000333493.4
ENST00000327655.6 |
GPR97
|
G protein-coupled receptor 97 |
| chr9_-_117150243 | 7.66 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
| chr4_-_84255935 | 7.60 |
ENST00000513463.1
|
HPSE
|
heparanase |
| chr6_+_42896865 | 7.59 |
ENST00000372836.4
ENST00000394142.3 |
CNPY3
|
canopy FGF signaling regulator 3 |
| chr17_-_7018128 | 7.59 |
ENST00000380952.2
ENST00000254850.7 |
ASGR2
|
asialoglycoprotein receptor 2 |
| chr22_+_17565841 | 7.53 |
ENST00000319363.6
|
IL17RA
|
interleukin 17 receptor A |
| chr17_-_72542278 | 7.53 |
ENST00000330793.1
|
CD300C
|
CD300c molecule |
| chr17_+_57784826 | 7.46 |
ENST00000262291.4
|
VMP1
|
vacuole membrane protein 1 |
| chr19_-_46526304 | 7.41 |
ENST00000008938.4
|
PGLYRP1
|
peptidoglycan recognition protein 1 |
| chr14_+_22739823 | 7.39 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
| chr15_+_81589254 | 7.39 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
| chr11_+_67171391 | 7.33 |
ENST00000312390.5
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr5_-_180236811 | 7.33 |
ENST00000446023.2
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr5_-_149829314 | 7.30 |
ENST00000407193.1
|
RPS14
|
ribosomal protein S14 |
| chr9_-_97402413 | 7.29 |
ENST00000414122.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr4_+_153021899 | 7.23 |
ENST00000509332.1
ENST00000504144.1 ENST00000499452.2 |
RP11-18H21.1
|
RP11-18H21.1 |
| chr11_-_67205538 | 7.23 |
ENST00000326294.3
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein |
| chr5_+_137801160 | 7.21 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
| chr1_-_161039647 | 7.17 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr14_+_97925151 | 7.14 |
ENST00000554862.1
ENST00000554260.1 ENST00000499910.2 |
CTD-2506J14.1
|
CTD-2506J14.1 |
| chr1_+_22351977 | 7.12 |
ENST00000420503.1
ENST00000416769.1 ENST00000404210.2 |
LINC00339
|
long intergenic non-protein coding RNA 339 |
| chr4_-_84256024 | 7.11 |
ENST00000311412.5
|
HPSE
|
heparanase |
| chr21_+_42742429 | 7.09 |
ENST00000418103.1
|
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
| chr12_-_6798410 | 7.09 |
ENST00000361959.3
ENST00000436774.2 ENST00000544482.1 |
ZNF384
|
zinc finger protein 384 |
| chr17_+_75449889 | 7.04 |
ENST00000590938.1
|
SEPT9
|
septin 9 |
| chr15_+_75074410 | 7.01 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
| chr11_+_67171358 | 7.00 |
ENST00000526387.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr5_+_96211643 | 6.98 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
| chr16_+_30087288 | 6.92 |
ENST00000279387.7
ENST00000562664.1 ENST00000562222.1 |
PPP4C
|
protein phosphatase 4, catalytic subunit |
| chr17_+_72733350 | 6.91 |
ENST00000392613.5
ENST00000392612.3 ENST00000392610.1 |
RAB37
|
RAB37, member RAS oncogene family |
| chr12_-_123201337 | 6.90 |
ENST00000528880.2
|
HCAR3
|
hydroxycarboxylic acid receptor 3 |
| chr19_+_13261216 | 6.87 |
ENST00000587885.1
ENST00000292433.3 |
IER2
|
immediate early response 2 |
| chr19_-_50083803 | 6.84 |
ENST00000391853.3
ENST00000339093.3 |
NOSIP
|
nitric oxide synthase interacting protein |
| chr22_+_38035623 | 6.81 |
ENST00000336738.5
ENST00000442465.2 |
SH3BP1
|
SH3-domain binding protein 1 |
| chr6_-_41909191 | 6.75 |
ENST00000512426.1
ENST00000372987.4 |
CCND3
|
cyclin D3 |
| chr12_+_9102632 | 6.74 |
ENST00000539240.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
| chr8_+_22462532 | 6.74 |
ENST00000389279.3
|
CCAR2
|
cell cycle and apoptosis regulator 2 |
| chr1_+_28995258 | 6.70 |
ENST00000361872.4
ENST00000294409.2 |
GMEB1
|
glucocorticoid modulatory element binding protein 1 |
| chr20_+_62367989 | 6.69 |
ENST00000309546.3
|
LIME1
|
Lck interacting transmembrane adaptor 1 |
| chr9_-_137809718 | 6.69 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
| chr11_+_1874200 | 6.67 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
| chr5_-_39274617 | 6.67 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
| chr20_-_1569278 | 6.64 |
ENST00000262929.5
ENST00000567028.1 |
SIRPB1
RP4-576H24.4
|
signal-regulatory protein beta 1 Uncharacterized protein |
| chr12_-_54867352 | 6.64 |
ENST00000305879.5
|
GTSF1
|
gametocyte specific factor 1 |
| chrX_-_153775760 | 6.62 |
ENST00000440967.1
ENST00000393564.2 ENST00000369620.2 |
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr2_+_65454863 | 6.60 |
ENST00000260641.5
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast) |
| chr22_-_37640456 | 6.58 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr20_+_814377 | 6.57 |
ENST00000304189.2
ENST00000381939.1 |
FAM110A
|
family with sequence similarity 110, member A |
| chr10_-_12237836 | 6.54 |
ENST00000444732.1
ENST00000378940.3 |
NUDT5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
| chr22_+_22020353 | 6.54 |
ENST00000456792.2
|
PPIL2
|
peptidylprolyl isomerase (cyclophilin)-like 2 |
| chr2_+_118572226 | 6.51 |
ENST00000263239.2
|
DDX18
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 |
| chr3_+_15469058 | 6.50 |
ENST00000432764.2
|
EAF1
|
ELL associated factor 1 |
| chr22_+_40342819 | 6.45 |
ENST00000407075.3
|
GRAP2
|
GRB2-related adaptor protein 2 |
| chr2_+_218994002 | 6.42 |
ENST00000428565.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr7_+_44084262 | 6.40 |
ENST00000456905.1
ENST00000440166.1 ENST00000452943.1 ENST00000468694.1 ENST00000494774.1 ENST00000490734.2 |
DBNL
|
drebrin-like |
| chr19_-_50083822 | 6.38 |
ENST00000596358.1
|
NOSIP
|
nitric oxide synthase interacting protein |
| chr19_+_55085248 | 6.33 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| chr1_+_40506392 | 6.30 |
ENST00000414893.1
ENST00000414281.1 ENST00000420216.1 ENST00000372792.2 ENST00000372798.1 ENST00000340450.3 ENST00000372805.3 ENST00000435719.1 ENST00000427843.1 ENST00000417287.1 ENST00000424977.1 ENST00000446031.1 |
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
| chr9_-_117150303 | 6.26 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
| chr5_-_149829244 | 6.26 |
ENST00000312037.5
|
RPS14
|
ribosomal protein S14 |
| chr16_+_77225071 | 6.26 |
ENST00000439557.2
ENST00000545553.1 |
MON1B
|
MON1 secretory trafficking family member B |
| chr2_-_42991257 | 6.25 |
ENST00000378661.2
|
OXER1
|
oxoeicosanoid (OXE) receptor 1 |
| chr11_-_64510409 | 6.23 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr13_-_30996373 | 6.22 |
ENST00000420694.1
|
LINC01058
|
long intergenic non-protein coding RNA 1058 |
| chr11_-_67169265 | 6.21 |
ENST00000358239.4
ENST00000376745.4 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
| chr11_-_67169253 | 6.21 |
ENST00000527663.1
ENST00000312989.7 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
| chr19_-_19754354 | 6.21 |
ENST00000587238.1
|
GMIP
|
GEM interacting protein |
| chr10_-_12237820 | 6.20 |
ENST00000378937.3
ENST00000378927.3 |
NUDT5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
| chr1_+_40862501 | 6.18 |
ENST00000539317.1
|
SMAP2
|
small ArfGAP2 |
| chr2_-_27294500 | 6.18 |
ENST00000447619.1
ENST00000429985.1 ENST00000456793.1 |
OST4
|
oligosaccharyltransferase 4 homolog (S. cerevisiae) |
| chr12_+_498500 | 6.18 |
ENST00000540180.1
ENST00000422000.1 ENST00000535052.1 |
CCDC77
|
coiled-coil domain containing 77 |
| chr17_+_72462525 | 6.15 |
ENST00000360141.3
|
CD300A
|
CD300a molecule |
| chr9_-_97401782 | 6.13 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr1_-_157789850 | 6.12 |
ENST00000491942.1
ENST00000358292.3 ENST00000368176.3 |
FCRL1
|
Fc receptor-like 1 |
| chr5_-_180237082 | 6.11 |
ENST00000506889.1
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr14_-_106830057 | 6.11 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr1_-_155990580 | 6.10 |
ENST00000531917.1
ENST00000480567.1 ENST00000526212.1 ENST00000529008.1 ENST00000496742.1 ENST00000295702.4 |
SSR2
|
signal sequence receptor, beta (translocon-associated protein beta) |
| chr1_-_204380919 | 6.10 |
ENST00000367188.4
|
PPP1R15B
|
protein phosphatase 1, regulatory subunit 15B |
| chr9_+_137772652 | 6.06 |
ENST00000350339.2
ENST00000291744.6 |
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2 |
| chr2_-_87018784 | 6.06 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
| chr2_+_65454926 | 6.06 |
ENST00000542850.1
ENST00000377982.4 |
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast) |
| chr11_+_809647 | 6.03 |
ENST00000321153.4
|
RPLP2
|
ribosomal protein, large, P2 |
| chr1_-_156786634 | 6.02 |
ENST00000392306.2
ENST00000368199.3 |
SH2D2A
|
SH2 domain containing 2A |
| chr11_-_417308 | 6.02 |
ENST00000397632.3
ENST00000382520.2 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr10_-_43904608 | 6.01 |
ENST00000337970.3
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F |
| chr18_+_3247413 | 6.00 |
ENST00000579226.1
ENST00000217652.3 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
| chr6_+_30034865 | 5.92 |
ENST00000376772.3
|
PPP1R11
|
protein phosphatase 1, regulatory (inhibitor) subunit 11 |
| chr2_+_218990428 | 5.90 |
ENST00000449014.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr10_-_43904235 | 5.90 |
ENST00000356053.3
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F |
| chr3_+_9834227 | 5.89 |
ENST00000287613.7
ENST00000397261.3 |
ARPC4
|
actin related protein 2/3 complex, subunit 4, 20kDa |
| chr17_-_29151686 | 5.86 |
ENST00000544695.1
|
CRLF3
|
cytokine receptor-like factor 3 |
| chr17_-_39093672 | 5.85 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
| chr19_+_41082755 | 5.85 |
ENST00000291842.5
ENST00000600733.1 |
SHKBP1
|
SH3KBP1 binding protein 1 |
| chr14_+_23341513 | 5.85 |
ENST00000546834.1
|
LRP10
|
low density lipoprotein receptor-related protein 10 |
| chr19_+_49838653 | 5.84 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chr17_+_72462766 | 5.84 |
ENST00000392625.3
ENST00000361933.3 ENST00000310828.5 |
CD300A
|
CD300a molecule |
| chr1_-_156786530 | 5.84 |
ENST00000368198.3
|
SH2D2A
|
SH2 domain containing 2A |
| chr16_-_69166460 | 5.83 |
ENST00000523421.1
ENST00000448552.2 ENST00000306585.6 ENST00000567763.1 ENST00000522497.1 ENST00000522091.1 ENST00000519520.1 |
CHTF8
|
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae) |
| chr18_+_77160282 | 5.83 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
| chr2_-_175547571 | 5.83 |
ENST00000409415.3
ENST00000359761.3 ENST00000272746.5 |
WIPF1
|
WAS/WASL interacting protein family, member 1 |
| chr15_+_75074385 | 5.82 |
ENST00000220003.9
|
CSK
|
c-src tyrosine kinase |
| chr7_-_143105941 | 5.81 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr21_-_46340770 | 5.79 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr1_+_154975110 | 5.79 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
| chr19_+_55417530 | 5.78 |
ENST00000350790.5
ENST00000338835.5 ENST00000357397.5 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
| chr7_-_5569588 | 5.78 |
ENST00000417101.1
|
ACTB
|
actin, beta |
| chr21_-_46359760 | 5.78 |
ENST00000330551.3
ENST00000397841.1 ENST00000380070.4 |
C21orf67
|
chromosome 21 open reading frame 67 |
| chr12_+_100660909 | 5.74 |
ENST00000549687.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
| chr11_+_118175596 | 5.73 |
ENST00000528600.1
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr19_+_46010674 | 5.72 |
ENST00000245932.6
ENST00000592139.1 ENST00000590603.1 |
VASP
|
vasodilator-stimulated phosphoprotein |
| chr4_+_71554196 | 5.71 |
ENST00000254803.2
|
UTP3
|
UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae) |
| chr2_-_74699770 | 5.70 |
ENST00000409710.1
|
MRPL53
|
mitochondrial ribosomal protein L53 |
| chr19_-_54327542 | 5.68 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
| chr5_-_149829294 | 5.67 |
ENST00000401695.3
|
RPS14
|
ribosomal protein S14 |
| chrX_+_48542168 | 5.67 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
| chr8_-_131028782 | 5.67 |
ENST00000519020.1
|
FAM49B
|
family with sequence similarity 49, member B |
| chr6_-_2842219 | 5.67 |
ENST00000380739.5
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
| chr7_-_97881429 | 5.66 |
ENST00000420697.1
ENST00000379795.3 ENST00000415086.1 ENST00000542604.1 ENST00000447648.2 |
TECPR1
|
tectonin beta-propeller repeat containing 1 |
| chr7_-_45018686 | 5.64 |
ENST00000258787.7
|
MYO1G
|
myosin IG |
| chr8_+_27169138 | 5.63 |
ENST00000522338.1
|
PTK2B
|
protein tyrosine kinase 2 beta |
| chr7_+_142000747 | 5.63 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr7_-_38403077 | 5.62 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
| chr19_-_39104556 | 5.60 |
ENST00000423454.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr9_-_134151915 | 5.60 |
ENST00000372271.3
|
FAM78A
|
family with sequence similarity 78, member A |
| chr19_+_55141948 | 5.57 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| chr14_-_23284703 | 5.57 |
ENST00000555911.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr19_+_41082802 | 5.53 |
ENST00000600718.1
|
SHKBP1
|
SH3KBP1 binding protein 1 |
| chr9_-_114937465 | 5.52 |
ENST00000355396.3
|
SUSD1
|
sushi domain containing 1 |
| chr8_+_56792377 | 5.51 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
| chr2_+_218989991 | 5.51 |
ENST00000453237.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr3_-_128880125 | 5.49 |
ENST00000393295.3
|
ISY1
|
ISY1 splicing factor homolog (S. cerevisiae) |
| chr7_-_142131914 | 5.49 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ELF2_GABPA_ELF5
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.8 | 47.7 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 4.7 | 14.1 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) |
| 4.5 | 36.0 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 4.5 | 17.9 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 4.3 | 17.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 4.2 | 16.8 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 4.2 | 12.5 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 4.0 | 4.0 | GO:2000451 | positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
| 4.0 | 19.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 3.8 | 3.8 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 3.7 | 11.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 3.6 | 18.0 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 3.5 | 17.5 | GO:0039506 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 3.4 | 17.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 3.4 | 16.9 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 3.3 | 13.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 3.3 | 13.3 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 3.3 | 13.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 3.3 | 3.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 3.2 | 3.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 3.2 | 9.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 3.2 | 16.1 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 3.2 | 9.6 | GO:0019085 | early viral transcription(GO:0019085) |
| 3.2 | 31.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 3.2 | 19.0 | GO:0043366 | beta selection(GO:0043366) |
| 3.0 | 9.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 3.0 | 9.1 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 3.0 | 17.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 2.9 | 2.9 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 2.9 | 29.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 2.9 | 29.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 2.9 | 8.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.8 | 8.4 | GO:0044782 | cilium organization(GO:0044782) |
| 2.8 | 11.1 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 2.8 | 5.5 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 2.7 | 8.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 2.7 | 24.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 2.7 | 8.0 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 2.6 | 2.6 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) |
| 2.6 | 7.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 2.6 | 23.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 2.6 | 5.1 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 2.5 | 10.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 2.5 | 7.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 2.5 | 17.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 2.5 | 12.4 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 2.5 | 7.4 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 2.4 | 9.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 2.4 | 7.2 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 2.4 | 16.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 2.3 | 11.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 2.3 | 9.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 2.3 | 6.9 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 2.3 | 11.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 2.3 | 13.6 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
| 2.2 | 15.7 | GO:2000769 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 2.2 | 15.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.2 | 6.6 | GO:0002384 | hepatic immune response(GO:0002384) |
| 2.2 | 15.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 2.2 | 8.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 2.2 | 2.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 2.1 | 14.7 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 2.1 | 2.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 2.1 | 16.6 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 2.1 | 4.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
| 2.1 | 6.2 | GO:1901656 | glycoside transport(GO:1901656) |
| 2.0 | 2.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 2.0 | 16.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 2.0 | 17.7 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 2.0 | 5.9 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 2.0 | 5.9 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 2.0 | 7.8 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.9 | 7.8 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.9 | 5.8 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 1.9 | 1.9 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
| 1.9 | 3.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 1.9 | 13.4 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 1.9 | 13.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 1.9 | 5.7 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 1.9 | 9.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 1.9 | 11.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 1.9 | 1.9 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 1.8 | 5.5 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 1.8 | 5.5 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 1.8 | 9.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.8 | 5.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 1.8 | 7.2 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 1.8 | 12.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 1.8 | 5.4 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 1.8 | 12.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 1.8 | 5.3 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 1.7 | 8.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.7 | 1.7 | GO:0033198 | response to ATP(GO:0033198) |
| 1.7 | 8.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 1.7 | 1.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 1.7 | 22.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 1.7 | 5.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 1.7 | 17.2 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 1.7 | 42.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 1.7 | 10.1 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 1.7 | 5.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 1.7 | 6.7 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 1.7 | 6.6 | GO:0051413 | response to cortisone(GO:0051413) |
| 1.6 | 4.9 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 1.6 | 8.2 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.6 | 4.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 1.6 | 13.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 1.6 | 4.9 | GO:0071529 | cementum mineralization(GO:0071529) |
| 1.6 | 14.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.6 | 4.9 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.6 | 36.8 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 1.6 | 7.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 1.6 | 1.6 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 1.6 | 12.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 1.6 | 3.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 1.6 | 9.5 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 1.6 | 6.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 1.6 | 7.9 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 1.6 | 7.8 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 1.6 | 4.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.5 | 4.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 1.5 | 4.6 | GO:0060661 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 1.5 | 6.1 | GO:0080009 | mRNA methylation(GO:0080009) |
| 1.5 | 6.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 1.5 | 10.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.5 | 6.0 | GO:0002432 | granuloma formation(GO:0002432) |
| 1.5 | 9.0 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 1.5 | 1.5 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 1.5 | 1.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 1.5 | 3.0 | GO:0043335 | protein unfolding(GO:0043335) |
| 1.5 | 4.4 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 1.5 | 8.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 1.5 | 5.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 1.5 | 5.8 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 1.5 | 14.5 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.4 | 15.9 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
| 1.4 | 1.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 1.4 | 11.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 1.4 | 7.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.4 | 7.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.4 | 1.4 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 1.4 | 11.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 1.4 | 1.4 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 1.4 | 12.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 1.4 | 9.8 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 1.4 | 4.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.4 | 9.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 1.4 | 1.4 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 1.4 | 2.7 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 1.4 | 2.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.4 | 20.5 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 1.4 | 4.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 1.4 | 8.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 1.3 | 4.0 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 1.3 | 5.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.3 | 8.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 1.3 | 2.6 | GO:0070781 | response to biotin(GO:0070781) |
| 1.3 | 11.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 1.3 | 3.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 1.3 | 6.5 | GO:0007172 | signal complex assembly(GO:0007172) |
| 1.3 | 9.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 1.3 | 11.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.3 | 3.9 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.3 | 23.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 1.3 | 5.1 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 1.3 | 3.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 1.3 | 6.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 1.3 | 3.8 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 1.3 | 6.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 1.3 | 7.5 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 1.3 | 188.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 1.2 | 5.0 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.2 | 5.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 1.2 | 3.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.2 | 3.7 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 1.2 | 14.8 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 1.2 | 4.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.2 | 11.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 1.2 | 4.9 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.2 | 3.7 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 1.2 | 9.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 1.2 | 7.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.2 | 14.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 1.2 | 21.7 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 1.2 | 2.4 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
| 1.2 | 3.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 1.2 | 3.6 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 1.2 | 10.8 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 1.2 | 13.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.2 | 12.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 1.2 | 2.3 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
| 1.2 | 8.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.2 | 2.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 1.2 | 1.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 1.2 | 2.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 1.2 | 8.1 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 1.2 | 8.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 1.2 | 2.3 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 1.2 | 3.5 | GO:0042100 | B cell proliferation(GO:0042100) |
| 1.2 | 13.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.2 | 3.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.1 | 3.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 1.1 | 2.3 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.1 | 3.4 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 1.1 | 2.3 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.1 | 27.3 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 1.1 | 4.5 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.1 | 2.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 1.1 | 5.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 1.1 | 38.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 1.1 | 6.8 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 1.1 | 3.4 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 1.1 | 5.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.1 | 14.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 1.1 | 4.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 1.1 | 1.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 1.1 | 12.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 1.1 | 3.3 | GO:1990169 | detoxification of copper ion(GO:0010273) regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) stress response to copper ion(GO:1990169) |
| 1.1 | 3.3 | GO:0032632 | interleukin-3 production(GO:0032632) |
| 1.1 | 8.7 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 1.1 | 28.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 1.1 | 5.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 1.1 | 35.6 | GO:0045730 | respiratory burst(GO:0045730) |
| 1.1 | 22.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.1 | 4.3 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 1.1 | 7.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
| 1.1 | 8.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 1.1 | 8.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 1.1 | 3.2 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 1.1 | 10.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.1 | 3.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 1.1 | 3.2 | GO:0061511 | centriole elongation(GO:0061511) |
| 1.1 | 4.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 1.1 | 7.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 1.1 | 3.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 1.1 | 3.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 1.1 | 20.0 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 1.1 | 7.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 1.0 | 4.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.0 | 8.3 | GO:0046618 | drug export(GO:0046618) |
| 1.0 | 14.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 1.0 | 3.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 1.0 | 2.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 1.0 | 1.0 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 1.0 | 5.1 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 1.0 | 1.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.0 | 2.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 1.0 | 3.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 1.0 | 7.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 1.0 | 8.1 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 1.0 | 4.0 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 1.0 | 24.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 1.0 | 2.0 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 1.0 | 2.0 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 1.0 | 4.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 1.0 | 5.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 1.0 | 3.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.0 | 2.0 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
| 1.0 | 17.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.0 | 5.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 1.0 | 15.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 1.0 | 2.9 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 1.0 | 5.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.0 | 2.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 1.0 | 71.2 | GO:0006968 | cellular defense response(GO:0006968) |
| 1.0 | 18.5 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 1.0 | 2.9 | GO:1990828 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 1.0 | 3.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.0 | 1.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 1.0 | 5.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 1.0 | 2.9 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 1.0 | 11.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 1.0 | 11.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 1.0 | 17.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 1.0 | 1.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 1.0 | 2.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 1.0 | 18.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 1.0 | 6.7 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 1.0 | 9.5 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.9 | 1.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.9 | 4.7 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.9 | 1.9 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.9 | 7.5 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.9 | 9.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.9 | 5.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.9 | 2.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.9 | 0.9 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
| 0.9 | 6.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.9 | 2.8 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.9 | 6.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.9 | 17.4 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.9 | 1.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.9 | 2.7 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.9 | 5.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.9 | 5.4 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.9 | 8.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.9 | 3.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.9 | 10.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.9 | 5.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.9 | 0.9 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.9 | 2.7 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.9 | 4.5 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.9 | 10.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.9 | 0.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.9 | 1.8 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.9 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.9 | 5.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.9 | 3.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.9 | 0.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.9 | 4.4 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.9 | 2.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.9 | 8.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.9 | 12.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.9 | 0.9 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.9 | 4.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.9 | 2.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.9 | 3.5 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.9 | 9.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.9 | 4.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.9 | 7.9 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.9 | 0.9 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.9 | 4.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.9 | 3.5 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.9 | 22.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.9 | 5.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.9 | 2.6 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.9 | 2.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.9 | 1.7 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.9 | 5.2 | GO:0015886 | heme transport(GO:0015886) |
| 0.9 | 21.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.9 | 5.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.9 | 3.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.9 | 2.6 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 0.8 | 6.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.8 | 3.4 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.8 | 10.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.8 | 3.4 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.8 | 4.2 | GO:0060154 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.8 | 5.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.8 | 1.7 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.8 | 16.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.8 | 4.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.8 | 4.2 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.8 | 2.5 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.8 | 0.8 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.8 | 2.5 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.8 | 2.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.8 | 6.6 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.8 | 0.8 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.8 | 7.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.8 | 2.5 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.8 | 14.0 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.8 | 1.6 | GO:0090150 | establishment of protein localization to membrane(GO:0090150) |
| 0.8 | 0.8 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.8 | 9.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.8 | 2.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.8 | 3.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.8 | 1.6 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.8 | 1.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.8 | 10.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.8 | 2.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.8 | 3.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.8 | 2.4 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.8 | 3.2 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
| 0.8 | 2.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.8 | 2.4 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.8 | 4.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.8 | 16.0 | GO:0008228 | opsonization(GO:0008228) |
| 0.8 | 4.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.8 | 8.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.8 | 4.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.8 | 6.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.8 | 3.2 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.8 | 3.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.8 | 18.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.8 | 0.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.8 | 1.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.8 | 3.2 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.8 | 2.4 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.8 | 4.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 | 2.4 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.8 | 7.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.8 | 3.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.8 | 7.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.8 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.8 | 1.6 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.8 | 2.3 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.8 | 1.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.8 | 6.9 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.8 | 5.4 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.8 | 4.6 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.8 | 0.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.8 | 4.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.8 | 2.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.8 | 2.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.8 | 1.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.8 | 23.7 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.8 | 3.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 0.8 | 16.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.8 | 3.8 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.8 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.8 | 9.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.8 | 18.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.8 | 5.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 | 0.8 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.8 | 2.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.8 | 8.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.8 | 0.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.7 | 13.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.7 | 13.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.7 | 8.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.7 | 10.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.7 | 2.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.7 | 21.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.7 | 0.7 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 | 1.5 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.7 | 0.7 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.7 | 2.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.7 | 1.5 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 | 3.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.7 | 2.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 | 1.5 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
| 0.7 | 3.6 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.7 | 10.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.7 | 8.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.7 | 20.3 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.7 | 1.4 | GO:2000449 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
| 0.7 | 2.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.7 | 0.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.7 | 6.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.7 | 0.7 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.7 | 11.5 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.7 | 1.4 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.7 | 6.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.7 | 270.4 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.7 | 7.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.7 | 479.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.7 | 0.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.7 | 2.1 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.7 | 7.7 | GO:0019081 | viral translation(GO:0019081) IRES-dependent viral translational initiation(GO:0075522) |
| 0.7 | 7.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.7 | 13.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.7 | 1.4 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.7 | 18.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.7 | 2.1 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.7 | 8.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.7 | 2.1 | GO:0061010 | external genitalia morphogenesis(GO:0035261) gall bladder development(GO:0061010) |
| 0.7 | 3.5 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.7 | 18.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.7 | 2.7 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.7 | 11.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.7 | 0.7 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.7 | 6.2 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.7 | 6.2 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.7 | 2.0 | GO:1904344 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.7 | 4.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.7 | 1.3 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.7 | 5.4 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.7 | 2.7 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.7 | 2.0 | GO:0070922 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
| 0.7 | 7.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.7 | 2.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.7 | 0.7 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.7 | 4.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.7 | 1.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.7 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.7 | 0.7 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.7 | 9.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.7 | 2.6 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.7 | 2.6 | GO:0060928 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.7 | 2.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.7 | 8.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.6 | 5.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.6 | 9.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.6 | 1.9 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.6 | 1.9 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 0.6 | 2.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.6 | 3.9 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.6 | 6.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.6 | 0.6 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.6 | 39.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.6 | 3.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 | 1.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.6 | 3.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.6 | 3.8 | GO:0006983 | ER overload response(GO:0006983) |
| 0.6 | 10.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.6 | 7.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.6 | 6.9 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.6 | 1.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.6 | 3.7 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.6 | 2.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) clathrin-coated pit assembly(GO:1905224) |
| 0.6 | 1.9 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.6 | 10.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.6 | 1.9 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.6 | 11.1 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.6 | 9.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.6 | 2.5 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.6 | 4.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 | 3.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.6 | 1.8 | GO:0042327 | positive regulation of phosphorylation(GO:0042327) |
| 0.6 | 1.8 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
| 0.6 | 0.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.6 | 9.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.6 | 1.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.6 | 3.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.6 | 10.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.6 | 1.8 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.6 | 2.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.6 | 8.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.6 | 1.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.6 | 3.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.6 | 1.2 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.6 | 4.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.6 | 1.2 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.6 | 1.2 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.6 | 9.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.6 | 4.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.6 | 0.6 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.6 | 3.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.6 | 0.6 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.6 | 4.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.6 | 11.3 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.6 | 1.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.6 | 5.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.6 | 1.8 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.6 | 6.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.6 | 1.2 | GO:0007613 | memory(GO:0007613) |
| 0.6 | 14.1 | GO:0039535 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) regulation of RIG-I signaling pathway(GO:0039535) |
| 0.6 | 2.3 | GO:1904587 | response to glycoprotein(GO:1904587) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.6 | 3.5 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.6 | 1.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
| 0.6 | 7.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.6 | 2.3 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.6 | 4.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.6 | 12.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.6 | 4.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.6 | 2.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.6 | 1.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 | 1.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 0.6 | 1.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.6 | 1.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.6 | 2.3 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.6 | 1.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.6 | 4.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.6 | 2.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.6 | 5.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.6 | 7.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.6 | 1.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.6 | 2.3 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.6 | 1.7 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.6 | 2.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.6 | 1.7 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.6 | 4.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.6 | 1.7 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.6 | 1.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.6 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.6 | 2.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.6 | 0.6 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
| 0.6 | 0.6 | GO:0051595 | response to methylglyoxal(GO:0051595) |
| 0.5 | 3.3 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.5 | 3.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.5 | 1.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.5 | 3.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.5 | 1.6 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
| 0.5 | 0.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.5 | 1.6 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.5 | 12.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.5 | 12.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.5 | 2.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.5 | 8.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.5 | 24.0 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.5 | 3.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.5 | 3.7 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.5 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.5 | 3.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.5 | 1.6 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.5 | 0.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.5 | 9.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.5 | 0.5 | GO:0006266 | DNA ligation(GO:0006266) |
| 0.5 | 6.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.5 | 2.6 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.5 | 3.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.5 | 1.6 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.5 | 0.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.5 | 2.1 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.5 | 5.7 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.5 | 3.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.5 | 3.6 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.5 | 2.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.5 | 2.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.5 | 1.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.5 | 1.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.5 | 1.5 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.5 | 20.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.5 | 0.5 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.5 | 3.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.5 | 1.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.5 | 1.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.5 | 5.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.5 | 31.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.5 | 3.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 | 1.0 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.5 | 10.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.5 | 10.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.5 | 2.5 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.5 | 1.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.5 | 1.0 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.5 | 1.0 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.5 | 1.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 | 1.5 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.5 | 9.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.5 | 15.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.5 | 2.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.5 | 7.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.5 | 2.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.5 | 0.5 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
| 0.5 | 2.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.5 | 2.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.5 | 0.5 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.5 | 10.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.5 | 5.4 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
| 0.5 | 7.4 | GO:0032329 | serine transport(GO:0032329) |
| 0.5 | 2.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.5 | 3.4 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.5 | 2.0 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
| 0.5 | 27.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.5 | 2.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.5 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.5 | 5.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.5 | 1.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.5 | 9.7 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 0.5 | 7.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.5 | 7.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.5 | 1.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.5 | 1.9 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.5 | 0.5 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.5 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.5 | 11.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.5 | 3.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.5 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 | 3.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.5 | 3.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.5 | 2.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 | 2.8 | GO:0016246 | RNA interference(GO:0016246) |
| 0.5 | 1.4 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.5 | 5.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.5 | 1.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.5 | 0.9 | GO:0051036 | regulation of multivesicular body size(GO:0010796) regulation of endosome size(GO:0051036) |
| 0.5 | 2.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.5 | 2.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.5 | 2.8 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.5 | 4.2 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.5 | 1.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.5 | 4.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.5 | 7.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.5 | 5.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.5 | 10.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.5 | 2.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.5 | 7.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.5 | 4.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.5 | 2.3 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.5 | 3.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.5 | 1.4 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.5 | 1.4 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.5 | 1.8 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.5 | 4.5 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
| 0.5 | 8.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.5 | 2.7 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.5 | 1.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.5 | 2.7 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.5 | 3.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.5 | 3.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.4 | 5.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.4 | 7.1 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.4 | 0.4 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.4 | 0.9 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.4 | 3.1 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.4 | 1.3 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.4 | 2.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.4 | 4.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.4 | 2.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.4 | 2.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.4 | 3.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.4 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.4 | 0.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.4 | 11.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.4 | 0.4 | GO:0031394 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.4 | 3.9 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.4 | 0.9 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.4 | 2.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.4 | 0.9 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.4 | 3.4 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.4 | 42.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.4 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.4 | 6.0 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.4 | 0.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.4 | 1.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.4 | 0.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.4 | 23.0 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.4 | 3.0 | GO:0072678 | T cell migration(GO:0072678) |
| 0.4 | 2.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 | 3.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.4 | 2.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.4 | 2.5 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.4 | 2.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.4 | 1.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.4 | 4.6 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.4 | 1.3 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.4 | 1.3 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.4 | 0.8 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.4 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.4 | 3.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.4 | 0.4 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
| 0.4 | 2.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.4 | 2.9 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.4 | 1.7 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
| 0.4 | 7.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.4 | 1.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.4 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 | 1.6 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.4 | 1.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.4 | 0.4 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.4 | 2.0 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.4 | 16.6 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.4 | 3.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.4 | 3.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.4 | 3.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.4 | 42.8 | GO:0006413 | translational initiation(GO:0006413) |
| 0.4 | 1.6 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.4 | 0.4 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.4 | 2.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.4 | 12.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.4 | 2.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.4 | 2.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.4 | 2.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 | 3.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.4 | 2.4 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 | 1.2 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.4 | 2.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.4 | 41.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.4 | 0.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.4 | 1.9 | GO:0045896 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) regulation of transcription during mitosis(GO:0045896) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.4 | 1.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.4 | 6.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.4 | 3.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.4 | 3.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.4 | 2.3 | GO:0002369 | T cell cytokine production(GO:0002369) |
| 0.4 | 1.9 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.4 | 2.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.4 | 1.5 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.4 | 2.3 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.4 | 2.3 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 | 7.2 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
| 0.4 | 13.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.4 | 12.9 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.4 | 0.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.4 | 1.1 | GO:0060022 | hard palate development(GO:0060022) |
| 0.4 | 3.4 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.4 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.4 | 2.6 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.4 | 1.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.4 | 1.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.4 | 1.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.4 | 2.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.4 | 1.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.4 | 4.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 1.5 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.4 | 0.7 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.4 | 2.2 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.4 | 1.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.4 | 1.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.4 | 3.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.4 | 1.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.4 | 3.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.4 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.4 | 7.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.4 | 12.0 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.4 | 22.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.4 | 1.4 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.4 | 1.4 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.4 | 1.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.4 | 2.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.4 | 11.1 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.4 | 3.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.4 | 2.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 20.0 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
| 0.4 | 1.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.4 | 1.4 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.4 | 4.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.4 | 0.7 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
| 0.4 | 23.7 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.4 | 20.8 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.4 | 1.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.4 | 0.4 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.4 | 1.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.4 | 2.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.3 | 2.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 | 1.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.3 | 2.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 | 0.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.3 | 2.8 | GO:0045007 | depurination(GO:0045007) |
| 0.3 | 10.0 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.3 | 6.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.3 | 2.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.3 | 1.0 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 0.3 | 1.4 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.3 | 1.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.3 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.3 | 1.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 5.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.3 | 3.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.3 | 5.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 1.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 | 4.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 | 3.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.3 | 3.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.3 | 15.4 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
| 0.3 | 2.7 | GO:0001503 | ossification(GO:0001503) |
| 0.3 | 9.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.3 | 1.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 8.6 | GO:0038066 | p38MAPK cascade(GO:0038066) regulation of p38MAPK cascade(GO:1900744) |
| 0.3 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 | 1.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.3 | 2.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.3 | 0.7 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.3 | 2.0 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.3 | 1.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.3 | 2.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 | 0.3 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.3 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.3 | 1.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.3 | 0.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.3 | 1.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.3 | 1.0 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.3 | 1.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.3 | 6.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.3 | 6.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 | 1.3 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.3 | 23.4 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.3 | 3.8 | GO:0015866 | ADP transport(GO:0015866) |
| 0.3 | 1.3 | GO:0061724 | lipophagy(GO:0061724) |
| 0.3 | 0.9 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.3 | 0.9 | GO:0035283 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.3 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
| 0.3 | 3.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.3 | 2.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.3 | 6.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.3 | 12.5 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.3 | 4.0 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.3 | 2.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.3 | 0.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.3 | 5.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.3 | 4.3 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.3 | 2.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.3 | 0.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.3 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 | 3.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.3 | 16.7 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.3 | 1.2 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.3 | 3.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.3 | 3.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.3 | 2.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.3 | 0.9 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.3 | 1.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.3 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.3 | 0.9 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.3 | 4.2 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.3 | 0.9 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 0.9 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.3 | 3.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.3 | 3.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.3 | 0.6 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
| 0.3 | 15.9 | GO:0007032 | endosome organization(GO:0007032) |
| 0.3 | 3.2 | GO:0007512 | adult heart development(GO:0007512) |
| 0.3 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.3 | 11.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.3 | 1.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.3 | 6.7 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.3 | 1.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 2.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.3 | 0.9 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.3 | 0.3 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.3 | 13.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 1.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.3 | 0.9 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.3 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 0.8 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.3 | 2.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 | 0.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.3 | 11.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.3 | 0.3 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 | 3.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.3 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.3 | 3.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.3 | 1.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.3 | 0.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 | 0.8 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 0.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 | 1.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.3 | 7.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.3 | 11.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.3 | 1.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 | 1.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.3 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.3 | 0.8 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 | 0.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.3 | 1.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.3 | 2.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.3 | 0.8 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 0.3 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.3 | 0.8 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.3 | 2.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 | 2.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.3 | 1.3 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.3 | 1.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.3 | 4.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.3 | 1.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.3 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.3 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.3 | 0.8 | GO:0051643 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) endoplasmic reticulum localization(GO:0051643) |
| 0.3 | 2.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 0.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.3 | 31.3 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.3 | 8.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.3 | 12.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.3 | 2.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.3 | 0.5 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.3 | 7.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.3 | 1.6 | GO:0060613 | fat pad development(GO:0060613) |
| 0.3 | 1.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.3 | 2.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 | 0.8 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.3 | 1.8 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.3 | 4.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.3 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.3 | 21.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.3 | 24.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.3 | 0.5 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.3 | 2.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 | 1.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 7.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.3 | 2.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.3 | 1.0 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.3 | 23.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.3 | 0.5 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.3 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.3 | 3.0 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.3 | 2.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 | 5.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.3 | 2.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.3 | 2.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 0.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 | 7.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
| 0.2 | 3.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.2 | 0.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.2 | 21.7 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
| 0.2 | 6.9 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.2 | 0.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.2 | 7.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.2 | 1.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.2 | 6.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.2 | 0.5 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 | 0.5 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.2 | 1.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.2 | 0.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.2 | 1.2 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 | 2.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 0.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.2 | 0.5 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.2 | 1.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 1.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.2 | 0.9 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.2 | 2.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 1.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 | 1.9 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
| 0.2 | 1.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.2 | 1.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.2 | 1.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 1.4 | GO:0072676 | lymphocyte migration(GO:0072676) |
| 0.2 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.2 | 1.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 0.2 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.2 | 0.5 | GO:1903333 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.2 | 1.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 7.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 2.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.2 | 1.4 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 0.2 | 0.5 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 | 1.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.2 | 1.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
| 0.2 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 | 2.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.2 | 0.9 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 0.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 | 0.4 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.2 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 | 2.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.2 | 7.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.2 | 0.7 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
| 0.2 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 | 1.1 | GO:0031929 | TOR signaling(GO:0031929) |
| 0.2 | 0.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 2.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.2 | 1.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.2 | 10.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.2 | 2.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 3.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 | 0.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 8.8 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.2 | 1.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 0.2 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.2 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.2 | 4.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.2 | 6.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.2 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.2 | 3.8 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.2 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 1.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 1.0 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.2 | 1.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.2 | 0.6 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.2 | 0.8 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.2 | 0.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.2 | 1.8 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
| 0.2 | 9.2 | GO:0051607 | defense response to virus(GO:0051607) |
| 0.2 | 6.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 0.2 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.2 | 0.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
| 0.2 | 4.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 | 2.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.2 | 0.8 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) |
| 0.2 | 0.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.2 | 3.6 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.2 | 1.2 | GO:0061087 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 0.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.2 | 3.6 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 2.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.2 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 1.4 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.2 | 2.8 | GO:0015893 | drug transport(GO:0015893) |
| 0.2 | 1.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 | 2.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.2 | 1.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.2 | 1.0 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
| 0.2 | 0.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.2 | 1.8 | GO:0070507 | regulation of microtubule cytoskeleton organization(GO:0070507) |
| 0.2 | 12.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 | 1.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 0.8 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 1.9 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.2 | 1.2 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 1.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.2 | 2.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 | 0.4 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.2 | 1.5 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.2 | 1.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 3.4 | GO:0002218 | activation of innate immune response(GO:0002218) |
| 0.2 | 0.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.2 | 1.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 0.8 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.2 | 2.0 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 1.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.2 | 1.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.2 | 1.3 | GO:0030819 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.2 | 1.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 21.4 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.2 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 1.3 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
| 0.2 | 0.4 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.2 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 1.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 1.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.2 | 9.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) DNA methylation or demethylation(GO:0044728) |
| 0.2 | 5.1 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
| 0.2 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.2 | 4.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.2 | 5.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 | 0.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 2.2 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
| 0.2 | 1.0 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.2 | 2.4 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.2 | 1.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.2 | 1.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.2 | 0.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.2 | 2.0 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 | 0.5 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.2 | 4.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.2 | 1.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.2 | 5.5 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
| 0.2 | 0.5 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.2 | 0.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 | 0.6 | GO:0042368 | vitamin D biosynthetic process(GO:0042368) |
| 0.2 | 3.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.2 | 0.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.2 | 13.8 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.2 | 0.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 1.1 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.2 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.2 | 0.8 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.2 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
| 0.2 | 1.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
| 0.2 | 1.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 | 1.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 0.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 | 11.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.2 | 5.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 1.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.2 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
| 0.2 | 0.5 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.1 | 1.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.1 | 0.6 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 1.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.6 | GO:0032633 | interleukin-4 production(GO:0032633) |
| 0.1 | 1.0 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.1 | 0.6 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 4.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 | 2.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.1 | 0.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 | 1.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 1.9 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
| 0.1 | 1.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.1 | 0.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.1 | 0.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 1.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 4.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.1 | 4.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 3.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 1.4 | GO:0050931 | pigment cell differentiation(GO:0050931) |
| 0.1 | 2.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 1.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 | 5.4 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 | 3.6 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.1 | 1.0 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 1.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 1.2 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
| 0.1 | 1.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.1 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 1.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 3.3 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.9 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 | 1.7 | GO:0014870 | response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 1.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 0.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 1.9 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.1 | 0.1 | GO:0009743 | response to carbohydrate(GO:0009743) |
| 0.1 | 0.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.1 | 0.4 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 | 0.5 | GO:0071472 | cellular response to salt stress(GO:0071472) |
| 0.1 | 2.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.9 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
| 0.1 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.1 | 1.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 2.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.6 | GO:0033602 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) aspartate secretion(GO:0061528) positive regulation of prolactin secretion(GO:1902722) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.1 | 2.7 | GO:0032438 | melanosome organization(GO:0032438) |
| 0.1 | 1.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 0.7 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.1 | 6.3 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 | 3.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.4 | GO:0060935 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.1 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 2.1 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.7 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
| 0.1 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 3.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 1.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 0.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.1 | 0.9 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
| 0.1 | 0.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 1.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.1 | 1.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 5.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 1.1 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.1 | 12.3 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.1 | 1.2 | GO:0031294 | lymphocyte costimulation(GO:0031294) |
| 0.1 | 0.9 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 2.9 | GO:0016197 | endosomal transport(GO:0016197) |
| 0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 | 1.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 2.4 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 0.3 | GO:0051180 | vitamin transport(GO:0051180) |
| 0.1 | 1.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 1.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
| 0.1 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.1 | 8.2 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
| 0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 2.5 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 1.1 | GO:1904385 | cellular response to angiotensin(GO:1904385) |
| 0.1 | 0.6 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.7 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 1.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.1 | 0.5 | GO:0045963 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 | 1.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.1 | 1.6 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 | 0.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.1 | 3.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 | 1.3 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.1 | 1.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.1 | 0.6 | GO:0030878 | thyroid gland development(GO:0030878) |
| 0.1 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.1 | 0.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.1 | 9.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.1 | 3.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 0.3 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 1.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.1 | 1.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.1 | 0.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 | 2.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.1 | 1.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.1 | GO:0043244 | regulation of protein complex disassembly(GO:0043244) |
| 0.1 | 0.8 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.1 | 0.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.1 | 1.8 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.1 | 2.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 0.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.1 | 1.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 4.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.1 | 0.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.1 | 1.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 3.5 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 0.3 | GO:0045089 | positive regulation of innate immune response(GO:0045089) |
| 0.1 | 0.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 | 0.6 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) |
| 0.1 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.2 | GO:0045471 | response to ethanol(GO:0045471) |
| 0.1 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.1 | 1.2 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 | 0.7 | GO:0043174 | nucleoside salvage(GO:0043174) |
| 0.1 | 1.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 | 0.2 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 | 1.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 1.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.6 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 1.3 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
| 0.1 | 1.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
| 0.1 | 0.7 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
| 0.1 | 0.3 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
| 0.1 | 1.6 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
| 0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.1 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 11.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.1 | 5.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.3 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.1 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.1 | 0.4 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
| 0.1 | 4.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 0.5 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 0.5 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
| 0.1 | 0.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.7 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 0.1 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) receptor biosynthetic process(GO:0032800) |
| 0.1 | 0.5 | GO:0008610 | lipid biosynthetic process(GO:0008610) |
| 0.1 | 0.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.3 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 2.0 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.1 | 0.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 2.0 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.1 | 0.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 7.0 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.1 | 6.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 0.2 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
| 0.1 | 1.3 | GO:0045727 | positive regulation of translation(GO:0045727) |
| 0.1 | 0.1 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.1 | 0.7 | GO:0043543 | protein acylation(GO:0043543) |
| 0.1 | 1.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 | 0.2 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
| 0.1 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
| 0.1 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.9 | GO:0060425 | lung morphogenesis(GO:0060425) |
| 0.1 | 0.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
| 0.1 | 0.6 | GO:0007099 | centriole replication(GO:0007099) |
| 0.1 | 1.0 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.4 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.1 | 0.7 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 0.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.1 | 1.1 | GO:0061620 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 0.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.1 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
| 0.1 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 0.2 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 0.9 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
| 0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 3.3 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.7 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.0 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 0.1 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 | 0.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 | 0.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.0 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.0 | 0.3 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.0 | 0.4 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 | 0.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 1.8 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
| 0.0 | 0.2 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 0.0 | 0.1 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.0 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 0.2 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.0 | 0.2 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.0 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
| 0.0 | 3.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.0 | 0.4 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.0 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 | 0.2 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
| 0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
| 0.0 | 0.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 | 0.4 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.3 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 2.1 | GO:0046777 | protein autophosphorylation(GO:0046777) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 4.0 | GO:0050776 | regulation of immune response(GO:0050776) |
| 0.0 | 0.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.0 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 | 2.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.0 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 | 1.1 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 1.0 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.0 | 0.1 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
| 0.0 | 0.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.0 | 0.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 | 0.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 1.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.0 | 0.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 | 0.0 | GO:0071426 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.0 | 0.1 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.0 | 0.1 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.0 | 0.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.0 | 0.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.2 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.0 | 0.3 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.0 | 0.2 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.0 | 0.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.0 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 0.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.5 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
| 0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.0 | 0.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.0 | 0.1 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.0 | 0.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.0 | 1.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.0 | 1.6 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
| 0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.0 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
| 0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
| 0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.0 | 0.0 | GO:0003094 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.0 | 0.0 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 | 11.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.0 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.0 | 0.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.0 | 0.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 0.0 | GO:0014823 | response to activity(GO:0014823) |
| 0.0 | 0.0 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 | 0.0 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 0.5 | GO:0000910 | cytokinesis(GO:0000910) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.4 | 37.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 3.8 | 11.5 | GO:0044609 | DBIRD complex(GO:0044609) |
| 3.8 | 11.3 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 3.7 | 14.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 3.4 | 27.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 3.4 | 10.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 3.3 | 43.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 3.1 | 12.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.9 | 8.8 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 2.9 | 25.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 2.5 | 7.5 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 2.4 | 9.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 2.4 | 9.4 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 2.3 | 11.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 2.2 | 13.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 2.2 | 11.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 2.1 | 8.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 2.1 | 12.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 2.1 | 12.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 2.0 | 21.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.9 | 46.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.9 | 7.6 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.8 | 9.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 1.8 | 8.9 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.8 | 10.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 1.8 | 16.0 | GO:0044194 | cytolytic granule(GO:0044194) |
| 1.8 | 42.5 | GO:0097342 | ripoptosome(GO:0097342) |
| 1.8 | 14.1 | GO:0032010 | phagolysosome(GO:0032010) |
| 1.7 | 6.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 1.7 | 6.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 1.7 | 6.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 1.7 | 36.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 1.6 | 4.9 | GO:0018444 | translation release factor complex(GO:0018444) |
| 1.6 | 4.9 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 1.6 | 1.6 | GO:0071817 | MMXD complex(GO:0071817) |
| 1.5 | 6.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 1.5 | 6.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 1.5 | 9.0 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 1.5 | 7.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 1.5 | 8.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 1.5 | 41.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.5 | 4.4 | GO:0034455 | t-UTP complex(GO:0034455) |
| 1.4 | 4.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 1.4 | 17.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.4 | 16.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 1.4 | 4.2 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 1.4 | 9.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 1.4 | 4.1 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 1.3 | 14.8 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 1.3 | 4.0 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 1.3 | 12.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 1.3 | 6.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 1.3 | 18.3 | GO:0071986 | Ragulator complex(GO:0071986) |
| 1.3 | 2.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.3 | 15.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 1.3 | 3.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 1.2 | 103.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 1.2 | 16.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 1.2 | 6.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 1.2 | 8.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 1.2 | 12.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 1.2 | 1.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 1.2 | 147.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 1.2 | 4.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 1.2 | 20.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 1.2 | 40.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 1.2 | 30.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 1.2 | 4.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 1.2 | 3.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 1.1 | 124.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 1.1 | 1.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 1.1 | 25.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.1 | 7.8 | GO:1990462 | omegasome(GO:1990462) |
| 1.1 | 4.5 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.1 | 3.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 1.1 | 2.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.1 | 2.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 1.1 | 1.1 | GO:0032059 | bleb(GO:0032059) |
| 1.0 | 9.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 1.0 | 55.3 | GO:0001772 | immunological synapse(GO:0001772) |
| 1.0 | 3.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 1.0 | 5.1 | GO:0031905 | early endosome lumen(GO:0031905) |
| 1.0 | 15.7 | GO:0032039 | integrator complex(GO:0032039) |
| 1.0 | 7.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 1.0 | 2.9 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 1.0 | 31.0 | GO:0032040 | small-subunit processome(GO:0032040) |
| 1.0 | 1.0 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 1.0 | 6.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 1.0 | 3.8 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 1.0 | 1.9 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 1.0 | 4.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 1.0 | 8.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.9 | 2.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.9 | 22.6 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.9 | 6.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.9 | 8.4 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.9 | 6.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.9 | 4.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.9 | 2.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.9 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.9 | 14.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.9 | 20.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.9 | 8.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.9 | 2.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.9 | 6.2 | GO:0032009 | early phagosome(GO:0032009) |
| 0.9 | 2.7 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.9 | 1.7 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.9 | 12.2 | GO:0000243 | commitment complex(GO:0000243) |
| 0.9 | 121.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.9 | 6.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.9 | 9.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.8 | 16.9 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.8 | 3.4 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.8 | 4.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.8 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
| 0.8 | 3.3 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.8 | 28.6 | GO:0031105 | septin complex(GO:0031105) |
| 0.8 | 20.4 | GO:0030684 | preribosome(GO:0030684) |
| 0.8 | 1.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.8 | 4.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.8 | 20.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.8 | 5.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.8 | 2.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.8 | 5.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.8 | 3.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.8 | 13.5 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.8 | 15.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.8 | 33.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.8 | 8.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.8 | 2.3 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 0.8 | 6.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.8 | 4.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.8 | 4.6 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.8 | 6.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.8 | 6.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.8 | 16.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.7 | 5.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.7 | 7.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.7 | 5.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.7 | 16.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.7 | 7.2 | GO:0097413 | Lewy body(GO:0097413) |
| 0.7 | 33.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.7 | 3.6 | GO:0005694 | chromosome(GO:0005694) |
| 0.7 | 2.1 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.7 | 0.7 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
| 0.7 | 6.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.7 | 24.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.7 | 2.1 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.7 | 4.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.7 | 4.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.7 | 2.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.7 | 23.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.7 | 6.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.7 | 9.4 | GO:0048500 | signal recognition particle(GO:0048500) |
| 0.7 | 2.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.7 | 16.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.7 | 7.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.7 | 4.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.7 | 58.0 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.7 | 2.6 | GO:0001652 | granular component(GO:0001652) |
| 0.7 | 41.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.7 | 2.0 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.6 | 5.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.6 | 5.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.6 | 109.2 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.6 | 0.6 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.6 | 3.8 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.6 | 2.5 | GO:0031523 | Myb complex(GO:0031523) |
| 0.6 | 2.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.6 | 19.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.6 | 6.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.6 | 3.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.6 | 8.0 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.6 | 3.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.6 | 54.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.6 | 1.2 | GO:0035101 | FACT complex(GO:0035101) |
| 0.6 | 19.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.6 | 1.8 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.6 | 4.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.6 | 0.6 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.6 | 29.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.6 | 4.0 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.6 | 2.8 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.6 | 1.7 | GO:0008623 | CHRAC(GO:0008623) |
| 0.6 | 5.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.6 | 3.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.6 | 12.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.6 | 14.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.6 | 1.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.6 | 7.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.6 | 26.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.6 | 8.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.6 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.6 | 1.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.5 | 2.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.5 | 3.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.5 | 7.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.5 | 1.6 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.5 | 5.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.5 | 2.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.5 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.5 | 40.5 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.5 | 2.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.5 | 4.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.5 | 3.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.5 | 2.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.5 | 11.4 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.5 | 3.1 | GO:0071203 | WASH complex(GO:0071203) |
| 0.5 | 8.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.5 | 1.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.5 | 3.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.5 | 4.0 | GO:0000805 | X chromosome(GO:0000805) Barr body(GO:0001740) |
| 0.5 | 6.0 | GO:0042555 | MCM complex(GO:0042555) |
| 0.5 | 5.0 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.5 | 7.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.5 | 8.4 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.5 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
| 0.5 | 33.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.5 | 4.3 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.5 | 4.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.5 | 14.2 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.5 | 5.2 | GO:0033503 | HULC complex(GO:0033503) |
| 0.5 | 7.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.5 | 4.7 | GO:0042599 | lamellar body(GO:0042599) |
| 0.5 | 5.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.5 | 0.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.5 | 9.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.5 | 2.3 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.5 | 12.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.5 | 2.3 | GO:0071942 | XPC complex(GO:0071942) |
| 0.5 | 1.8 | GO:0032449 | CBM complex(GO:0032449) |
| 0.5 | 4.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.5 | 2.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.5 | 3.2 | GO:0042581 | specific granule(GO:0042581) |
| 0.5 | 7.7 | GO:0090543 | Flemming body(GO:0090543) |
| 0.5 | 4.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.5 | 15.9 | GO:0000791 | euchromatin(GO:0000791) |
| 0.5 | 80.7 | GO:0016605 | PML body(GO:0016605) |
| 0.4 | 0.9 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.4 | 14.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.4 | 1.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.4 | 8.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.4 | 5.8 | GO:0097433 | dense body(GO:0097433) |
| 0.4 | 9.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.4 | 1.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.4 | 49.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.4 | 9.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.4 | 3.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.4 | 6.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.4 | 3.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.4 | 0.8 | GO:0043601 | nuclear replisome(GO:0043601) |
| 0.4 | 4.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.4 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.4 | 39.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.4 | 4.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.4 | 2.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.4 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.4 | 2.4 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.4 | 1.2 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.4 | 1.6 | GO:0031251 | PAN complex(GO:0031251) |
| 0.4 | 2.7 | GO:0030891 | VCB complex(GO:0030891) |
| 0.4 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.4 | 1.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.4 | 1.1 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.4 | 3.4 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.4 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.4 | 25.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.4 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
| 0.4 | 52.5 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.4 | 6.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.4 | 85.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.4 | 35.6 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.4 | 4.5 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.4 | 0.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.4 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.4 | 2.6 | GO:0098536 | deuterosome(GO:0098536) |
| 0.4 | 3.7 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.4 | 2.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.4 | 1.8 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.4 | 1.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.4 | 1.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.4 | 2.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.4 | 1.8 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.4 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.4 | 6.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.4 | 31.3 | GO:0005776 | autophagosome(GO:0005776) |
| 0.4 | 1.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.4 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
| 0.3 | 3.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.3 | 1.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.3 | 49.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.3 | 2.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.3 | 15.4 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 15.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.3 | 24.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.3 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 2.0 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.3 | 1.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.3 | 4.7 | GO:0010369 | chromocenter(GO:0010369) |
| 0.3 | 5.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.3 | 1.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.3 | 3.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 2.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.3 | 5.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 1.3 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.3 | 0.3 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.3 | 155.3 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.3 | 12.2 | GO:0000922 | spindle pole(GO:0000922) |
| 0.3 | 9.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.3 | 2.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.3 | 33.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.3 | 52.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.3 | 5.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 7.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 3.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.3 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.3 | 2.7 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 1.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.3 | 7.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.3 | 3.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.3 | 3.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.3 | 4.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.3 | 3.2 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.3 | 2.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.3 | 6.9 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.3 | 6.9 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.3 | 82.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.3 | 11.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.3 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.3 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 2.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 3.4 | GO:0005657 | replication fork(GO:0005657) |
| 0.3 | 4.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.3 | 3.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.3 | 27.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.3 | 1.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.3 | 84.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.3 | 3.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.3 | 2.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 11.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.3 | 3.0 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.3 | 9.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 1.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.3 | 13.7 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.3 | 6.4 | GO:0042627 | chylomicron(GO:0042627) |
| 0.3 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.3 | 1.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.3 | 1.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.3 | 64.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.2 | 0.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.2 | 3.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.2 | 2.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 0.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.2 | 2.4 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.2 | 5.0 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.2 | 1.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 6.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.2 | 4.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 86.2 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.2 | 1.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 1.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.2 | 1.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 1.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 1.7 | GO:0038201 | TOR complex(GO:0038201) |
| 0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.2 | 2.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.2 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.2 | 1.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.2 | 0.8 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.2 | 9.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 20.0 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.2 | 27.3 | GO:0005840 | ribosome(GO:0005840) |
| 0.2 | 5.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.2 | 14.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.2 | 1.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 1.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 3.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 0.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 24.3 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.2 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 4.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.2 | 21.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.2 | 8.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.2 | 0.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.2 | 5.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.2 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.2 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 14.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 2.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.2 | 20.2 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 0.8 | GO:0044232 | organelle membrane contact site(GO:0044232) ER-mitochondrion membrane contact site(GO:0044233) |
| 0.2 | 1.7 | GO:0030904 | retromer complex(GO:0030904) |
| 0.2 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
| 0.2 | 1.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.2 | 2.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 2.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 4.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 1.3 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
| 0.1 | 0.7 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.1 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 81.0 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 9.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) cytoplasmic side of membrane(GO:0098562) |
| 0.1 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 2.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.1 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 3.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.9 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 0.8 | GO:0032421 | stereocilium(GO:0032420) stereocilium bundle(GO:0032421) |
| 0.1 | 3.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.1 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 4.9 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 5.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 3.1 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 12.0 | GO:0005635 | nuclear envelope(GO:0005635) |
| 0.1 | 1.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 12.6 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 1.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.7 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 315.9 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.1 | 9.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 2.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 4.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 3.7 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 0.8 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.1 | 10.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.1 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 19.8 | GO:0016020 | membrane(GO:0016020) |
| 0.1 | 19.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 3.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 2.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 1.0 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 0.7 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.1 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 1.8 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.1 | 0.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 8.8 | GO:0019867 | outer membrane(GO:0019867) |
| 0.1 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.6 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 0.8 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 3.5 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 4.4 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 236.3 | GO:0005829 | cytosol(GO:0005829) |
| 0.1 | 5.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 0.1 | 2.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.0 | 4.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.8 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.0 | 0.3 | GO:1990234 | transferase complex(GO:1990234) |
| 0.0 | 0.7 | GO:0008305 | integrin complex(GO:0008305) |
| 0.0 | 0.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 0.3 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.0 | 3.3 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 1.7 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 89.9 | GO:0005634 | nucleus(GO:0005634) |
| 0.0 | 133.0 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 1.5 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 1.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 0.4 | GO:0005768 | endosome(GO:0005768) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.7 | 40.5 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 5.4 | 21.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 4.9 | 9.7 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 4.5 | 17.9 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 4.3 | 17.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 4.2 | 16.7 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 4.0 | 16.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 3.8 | 15.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 3.8 | 18.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 3.6 | 18.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 3.3 | 13.2 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 3.0 | 9.0 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 3.0 | 3.0 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 3.0 | 20.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 3.0 | 11.9 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 2.7 | 35.3 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 2.7 | 24.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 2.7 | 8.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 2.7 | 2.7 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 2.6 | 7.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 2.6 | 7.9 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 2.6 | 10.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 2.5 | 7.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 2.5 | 12.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 2.4 | 9.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 2.4 | 7.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 2.4 | 11.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 2.3 | 27.5 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 2.2 | 11.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 2.2 | 6.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 2.2 | 2.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 2.2 | 6.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 2.1 | 18.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 2.1 | 10.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 2.0 | 14.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 2.0 | 8.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 2.0 | 10.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 2.0 | 31.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 2.0 | 5.9 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 1.9 | 11.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.9 | 5.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 1.9 | 7.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 1.9 | 13.3 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 1.9 | 1.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 1.9 | 7.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 1.8 | 3.7 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 1.8 | 5.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 1.8 | 1.8 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 1.8 | 1.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 1.8 | 23.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.8 | 10.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 1.8 | 5.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 1.8 | 3.5 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 1.7 | 6.9 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 1.7 | 6.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 1.7 | 12.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 1.7 | 8.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 1.7 | 5.1 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 1.7 | 11.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 1.7 | 10.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 1.7 | 10.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 1.7 | 13.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.6 | 8.2 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 1.6 | 32.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 1.6 | 19.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.6 | 11.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.6 | 4.8 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 1.6 | 7.9 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 1.6 | 1.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.6 | 18.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.6 | 6.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.5 | 7.6 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 1.5 | 7.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.5 | 6.0 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 1.5 | 4.4 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 1.5 | 8.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 1.5 | 4.4 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 1.4 | 5.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.4 | 2.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 1.4 | 1.4 | GO:0019956 | chemokine binding(GO:0019956) |
| 1.4 | 5.6 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 1.4 | 15.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 1.4 | 5.5 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 1.4 | 19.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 1.4 | 12.3 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 1.4 | 4.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 1.4 | 4.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 1.4 | 5.4 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 1.3 | 4.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 1.3 | 8.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.3 | 4.0 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 1.3 | 13.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 1.3 | 4.0 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 1.3 | 12.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 1.3 | 11.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 1.3 | 5.3 | GO:0004803 | transposase activity(GO:0004803) |
| 1.3 | 6.6 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 1.3 | 9.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 1.3 | 3.9 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.3 | 2.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 1.3 | 10.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 1.3 | 10.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 1.3 | 2.5 | GO:0046979 | TAP2 binding(GO:0046979) |
| 1.3 | 5.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 1.3 | 12.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 1.3 | 8.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.3 | 7.5 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 1.2 | 3.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 1.2 | 12.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 1.2 | 3.7 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 1.2 | 8.6 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 1.2 | 13.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 1.2 | 3.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 1.2 | 12.1 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 1.2 | 12.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 1.2 | 3.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 1.2 | 10.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 1.2 | 2.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 1.2 | 4.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.2 | 8.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 1.2 | 4.6 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 1.2 | 3.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 1.1 | 4.6 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 1.1 | 10.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 1.1 | 3.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.1 | 4.6 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
| 1.1 | 19.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 1.1 | 3.4 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 1.1 | 3.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 1.1 | 3.3 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 1.1 | 6.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 1.1 | 6.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.1 | 4.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 1.1 | 4.3 | GO:0019862 | IgA binding(GO:0019862) |
| 1.1 | 6.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 1.1 | 8.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 1.1 | 3.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 1.1 | 7.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.1 | 13.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 1.1 | 9.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.1 | 3.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.1 | 5.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 1.1 | 3.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 1.0 | 4.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 1.0 | 4.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 1.0 | 3.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 1.0 | 9.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 1.0 | 26.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 1.0 | 3.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 1.0 | 3.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 1.0 | 3.0 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.0 | 23.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 1.0 | 7.0 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.0 | 2.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
| 1.0 | 4.0 | GO:0035877 | death effector domain binding(GO:0035877) |
| 1.0 | 62.5 | GO:0019843 | rRNA binding(GO:0019843) |
| 1.0 | 10.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.0 | 16.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 1.0 | 4.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 1.0 | 3.9 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 1.0 | 4.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 1.0 | 7.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 1.0 | 38.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 1.0 | 29.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 1.0 | 4.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 1.0 | 3.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 1.0 | 2.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 1.0 | 5.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.9 | 16.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.9 | 9.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.9 | 4.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.9 | 7.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.9 | 28.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.9 | 5.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.9 | 2.8 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.9 | 2.8 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.9 | 2.7 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.9 | 21.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.9 | 8.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.9 | 3.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.9 | 3.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.9 | 1.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.9 | 3.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.9 | 3.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.9 | 4.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.9 | 9.0 | GO:0089720 | caspase binding(GO:0089720) |
| 0.9 | 15.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.9 | 8.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.9 | 20.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.9 | 11.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.9 | 2.7 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.9 | 2.7 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.9 | 4.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.9 | 3.5 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.9 | 11.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.9 | 27.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.9 | 2.6 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.9 | 3.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.9 | 0.9 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.9 | 2.6 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.9 | 29.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.9 | 2.6 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.9 | 9.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.9 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.8 | 3.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.8 | 8.5 | GO:0019863 | IgE binding(GO:0019863) |
| 0.8 | 2.5 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.8 | 6.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.8 | 3.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.8 | 15.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.8 | 24.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.8 | 2.5 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.8 | 10.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.8 | 18.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.8 | 3.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.8 | 11.6 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.8 | 1.6 | GO:0048256 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
| 0.8 | 7.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.8 | 4.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.8 | 2.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.8 | 21.8 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.8 | 9.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.8 | 2.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.8 | 4.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.8 | 4.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.8 | 7.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.8 | 3.2 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.8 | 70.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.8 | 5.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.8 | 3.2 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.8 | 22.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.8 | 6.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.8 | 3.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.8 | 2.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.8 | 2.3 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.8 | 29.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.8 | 23.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.8 | 8.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.8 | 3.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.7 | 10.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.7 | 2.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.7 | 4.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.7 | 13.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.7 | 9.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.7 | 4.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.7 | 3.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.7 | 2.9 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.7 | 8.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.7 | 15.8 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.7 | 2.9 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.7 | 0.7 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.7 | 10.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.7 | 2.8 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.7 | 39.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.7 | 25.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.7 | 4.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.7 | 3.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.7 | 2.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.7 | 1.4 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.7 | 35.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.7 | 9.8 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.7 | 2.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.7 | 2.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.7 | 2.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.7 | 4.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.7 | 16.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.7 | 2.0 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
| 0.7 | 4.1 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.7 | 5.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.7 | 2.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.7 | 12.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.7 | 2.7 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.7 | 4.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.7 | 6.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.7 | 2.0 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.7 | 4.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.7 | 1.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.7 | 13.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.7 | 1.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.7 | 137.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.7 | 2.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.7 | 4.6 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.7 | 21.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.7 | 2.0 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.7 | 6.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.7 | 4.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.7 | 2.6 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.7 | 7.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.6 | 1.9 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.6 | 3.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.6 | 1.9 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.6 | 3.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.6 | 3.9 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.6 | 12.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.6 | 1.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.6 | 3.8 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.6 | 3.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.6 | 6.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.6 | 5.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.6 | 10.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.6 | 1.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.6 | 6.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.6 | 41.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.6 | 3.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.6 | 1.9 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.6 | 1.9 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.6 | 2.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.6 | 10.5 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.6 | 20.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.6 | 11.0 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.6 | 56.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.6 | 4.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.6 | 1.8 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.6 | 1.8 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.6 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.6 | 5.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.6 | 2.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 1.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.6 | 3.0 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.6 | 4.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.6 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.6 | 21.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.6 | 4.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.6 | 4.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.6 | 24.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.6 | 6.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.6 | 2.3 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.6 | 3.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.6 | 4.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.6 | 1.1 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.6 | 9.6 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.6 | 2.8 | GO:0042806 | fucose binding(GO:0042806) |
| 0.6 | 2.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.6 | 1.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.6 | 4.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.6 | 1.7 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.6 | 2.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.6 | 15.1 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.6 | 3.3 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.6 | 1.7 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.6 | 3.3 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.6 | 2.8 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.6 | 3.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.6 | 7.7 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.6 | 24.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.6 | 2.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.6 | 12.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.5 | 23.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.5 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.5 | 1.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.5 | 1.6 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.5 | 1.6 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.5 | 21.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.5 | 3.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.5 | 8.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.5 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.5 | 2.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.5 | 8.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.5 | 3.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.5 | 2.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.5 | 4.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.5 | 3.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.5 | 2.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.5 | 3.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 4.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.5 | 3.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.5 | 74.0 | GO:0003823 | antigen binding(GO:0003823) |
| 0.5 | 17.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.5 | 9.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.5 | 7.7 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.5 | 4.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.5 | 5.1 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.5 | 1.0 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.5 | 23.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.5 | 3.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.5 | 2.0 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.5 | 1.5 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.5 | 1.5 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.5 | 0.5 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.5 | 2.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.5 | 11.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.5 | 2.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.5 | 5.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.5 | 2.0 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.5 | 1.5 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.5 | 42.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.5 | 3.9 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.5 | 11.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.5 | 10.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.5 | 3.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.5 | 5.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.5 | 4.8 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.5 | 28.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.5 | 5.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.5 | 1.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.5 | 2.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.5 | 6.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.5 | 2.3 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.5 | 1.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.5 | 1.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.5 | 2.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.5 | 2.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.5 | 3.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.5 | 3.7 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.5 | 8.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.5 | 3.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.5 | 11.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.5 | 1.8 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.5 | 3.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.5 | 7.8 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.5 | 1.8 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.5 | 1.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.5 | 5.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.5 | 1.8 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.5 | 1.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.5 | 23.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.4 | 1.3 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.4 | 4.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.4 | 0.4 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.4 | 1.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.4 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.4 | 1.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.4 | 11.5 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
| 0.4 | 2.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.4 | 3.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.4 | 1.7 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.4 | 3.0 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 14.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.4 | 17.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.4 | 1.3 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.4 | 1.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.4 | 6.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.4 | 19.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.4 | 3.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.4 | 1.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.4 | 2.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.4 | 0.8 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 0.4 | 2.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.4 | 13.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.4 | 3.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.4 | 1.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.4 | 1.3 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.4 | 7.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.4 | 4.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.4 | 2.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.4 | 4.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.4 | 1.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.4 | 7.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.4 | 13.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.4 | 1.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.4 | 1.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.4 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.4 | 1.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.4 | 1.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.4 | 3.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 2.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.4 | 4.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.4 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.4 | 4.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.4 | 2.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.4 | 11.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.4 | 16.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.4 | 7.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.4 | 12.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.4 | 11.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.4 | 10.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 12.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.4 | 16.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.4 | 2.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.4 | 1.2 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.4 | 1.5 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.4 | 5.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.4 | 3.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.4 | 17.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.4 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.4 | 1.1 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.4 | 5.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.4 | 1.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.4 | 2.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.4 | 1.5 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.4 | 1.1 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.4 | 18.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.4 | 1.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.4 | 2.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 2.9 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.4 | 13.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.4 | 6.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.4 | 2.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.4 | 1.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.4 | 8.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.4 | 1.4 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.4 | 1.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.4 | 3.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.3 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.3 | 1.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.3 | 2.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 1.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.3 | 1.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.3 | 3.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.3 | 1.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.3 | 14.5 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.3 | 5.1 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.3 | 1.0 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.3 | 19.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.3 | 4.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 2.3 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 29.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 6.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.3 | 1.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.3 | 2.3 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 1.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.3 | 1.3 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.3 | 2.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.3 | 1.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.3 | 2.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 2.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.3 | 18.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.3 | 10.9 | GO:0043531 | ADP binding(GO:0043531) |
| 0.3 | 1.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.3 | 3.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.3 | 3.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.3 | 3.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.3 | 2.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.3 | 3.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.3 | 1.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.3 | 1.3 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 1.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.3 | 8.1 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.3 | 17.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.3 | 19.3 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.3 | 1.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.3 | 0.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.3 | 4.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.3 | 2.7 | GO:0042835 | BRE binding(GO:0042835) |
| 0.3 | 0.9 | GO:0019003 | GDP binding(GO:0019003) |
| 0.3 | 0.9 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.3 | 6.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.3 | 0.9 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.3 | 4.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.3 | 21.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.3 | 3.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 6.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 3.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.3 | 1.2 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.3 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.3 | 1.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.3 | 2.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 2.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.3 | 20.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.3 | 1.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 1.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.3 | 12.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 9.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 2.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.3 | 3.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.3 | 7.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.3 | 1.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 0.8 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.3 | 15.5 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.3 | 1.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.3 | 1.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.3 | 9.9 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.3 | 3.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.3 | 1.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.3 | 0.8 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.3 | 10.6 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.3 | 2.7 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.3 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.3 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 2.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.3 | 0.8 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.3 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 4.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.3 | 2.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.3 | 0.8 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.3 | 3.6 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.3 | 1.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.3 | 6.0 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.3 | 3.9 | GO:0019864 | IgG binding(GO:0019864) |
| 0.3 | 16.1 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.3 | 8.8 | GO:0005525 | GTP binding(GO:0005525) |
| 0.3 | 1.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.3 | 1.8 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.3 | 49.8 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.3 | 3.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.3 | 0.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.3 | 7.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.3 | 2.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 1.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
| 0.2 | 20.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.2 | 8.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 2.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 2.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.2 | 22.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.2 | 124.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
| 0.2 | 1.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.2 | 2.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 1.0 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 7.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.2 | 4.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.2 | 0.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.2 | 30.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.2 | 3.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 2.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 2.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.2 | 0.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.2 | 0.5 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.2 | 1.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.2 | 1.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 18.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 3.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 1.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.2 | 6.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 13.6 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.2 | 1.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 6.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 1.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.2 | 1.6 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
| 0.2 | 1.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 1.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 1.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 2.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.2 | 2.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.2 | 27.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.2 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 0.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 7.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.2 | 0.9 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.2 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.2 | 1.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.2 | 1.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.2 | 5.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.2 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 8.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 25.7 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.2 | 2.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.2 | 0.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.2 | 15.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.2 | 0.6 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
| 0.2 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.2 | 1.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.2 | 3.3 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 3.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 1.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.2 | 1.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.2 | 1.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.2 | 4.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 69.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.2 | 3.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 6.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.2 | 6.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 31.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.2 | 0.8 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 6.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.2 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.2 | 0.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.2 | 0.6 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.2 | 1.0 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.2 | 1.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.2 | 2.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 0.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.2 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.2 | 3.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 1.1 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.2 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.2 | 69.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.2 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.2 | 0.7 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.2 | 0.9 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 8.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 2.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.2 | 2.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 6.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 2.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.2 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 3.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 1.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.2 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.2 | 1.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.2 | 1.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 1.5 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 5.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.2 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 57.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.2 | 1.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.2 | 2.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.2 | 3.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.2 | 0.8 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.2 | 1.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.2 | 0.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.2 | 0.3 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 7.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.2 | 1.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 0.6 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.2 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.2 | 0.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.2 | 0.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 2.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 8.5 | GO:0004518 | nuclease activity(GO:0004518) |
| 0.2 | 14.4 | GO:0042393 | histone binding(GO:0042393) |
| 0.2 | 0.5 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 0.8 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 6.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.2 | 1.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 0.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 1.2 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.2 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 4.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 1.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 1.6 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 19.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 23.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.4 | GO:0047017 | geranylgeranyl reductase activity(GO:0045550) prostaglandin-F synthase activity(GO:0047017) |
| 0.1 | 16.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 3.3 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.1 | 0.4 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.1 | 1.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.8 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 1.0 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.1 | 0.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 0.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 3.2 | GO:0001614 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.7 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.1 | 1.7 | GO:0019955 | cytokine binding(GO:0019955) |
| 0.1 | 0.8 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 2.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 6.4 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
| 0.1 | 2.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 0.1 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 1.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 1.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 28.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
| 0.1 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.1 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.6 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 3.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 0.4 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.1 | 1.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.1 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.1 | 0.9 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 18.4 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
| 0.1 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 0.4 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.1 | 1.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.5 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 0.7 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.1 | 0.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 0.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 0.1 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.1 | 2.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 5.4 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 1.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 1.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.1 | 4.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.1 | 2.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 1.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 4.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 3.3 | GO:0004871 | signal transducer activity(GO:0004871) |
| 0.1 | 1.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 0.3 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.1 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 1.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 5.1 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 2.5 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
| 0.1 | 24.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 1.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 1.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 2.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.1 | 2.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 1.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.3 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.1 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 1.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 2.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 0.2 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
| 0.1 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 17.7 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 7.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 4.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 2.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.2 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
| 0.1 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 1.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 3.9 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 38.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.1 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
| 0.1 | 1.8 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 5.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.1 | 0.4 | GO:0030613 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 127.4 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 0.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.1 | 0.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.1 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.1 | 0.5 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 6.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
| 0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.1 | 0.2 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.1 | 1.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.1 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.1 | 0.5 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.1 | 0.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.0 | 0.1 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.0 | 7.1 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.0 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.0 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.0 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.0 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.9 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.0 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 2.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 40.9 | GO:0003723 | RNA binding(GO:0003723) |
| 0.0 | 0.2 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.0 | 0.2 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 1.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.0 | 8.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.0 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.1 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
| 0.0 | 0.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.0 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.0 | 0.4 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 0.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.7 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.0 | 0.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.0 | 0.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.0 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
| 0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.1 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.0 | 0.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.0 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.0 | 0.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 4.3 | GO:0008270 | zinc ion binding(GO:0008270) |
| 0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.1 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.0 | 1.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
| 0.0 | 0.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 7.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 1.7 | 24.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 1.7 | 208.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 1.5 | 1.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.4 | 52.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 1.3 | 47.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 1.2 | 78.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 1.2 | 80.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 1.1 | 43.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 1.0 | 27.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 1.0 | 37.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 1.0 | 19.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 1.0 | 41.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.9 | 84.7 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.9 | 46.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.8 | 21.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.8 | 21.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.8 | 31.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.8 | 21.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.8 | 5.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.7 | 21.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.7 | 16.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.7 | 51.5 | PID ATM PATHWAY | ATM pathway |
| 0.6 | 6.3 | PID EPO PATHWAY | EPO signaling pathway |
| 0.6 | 32.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.6 | 1.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.6 | 16.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.6 | 7.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.6 | 27.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.5 | 50.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.5 | 64.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.5 | 13.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.5 | 20.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.5 | 4.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.5 | 5.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.4 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.4 | 2.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.4 | 15.8 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.4 | 4.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.4 | 6.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 9.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.4 | 11.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.4 | 12.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.4 | 4.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.4 | 8.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.4 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.4 | 6.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.4 | 19.8 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.4 | 19.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.4 | 43.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.4 | 8.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.3 | 12.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.3 | 12.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.3 | 15.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 12.7 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.3 | 4.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.3 | 11.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.3 | 22.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.3 | 11.9 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.3 | 12.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.3 | 8.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.3 | 24.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.3 | 26.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.3 | 2.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.3 | 11.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.3 | 9.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.3 | 10.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.3 | 2.4 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 19.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.3 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.3 | 18.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 8.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.3 | 8.7 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.3 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 12.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 5.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 11.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 11.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.2 | 12.7 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 15.1 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 2.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 7.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.2 | 5.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 17.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.2 | 23.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.2 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 2.0 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 4.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.2 | 2.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.2 | 18.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 3.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.2 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.2 | 6.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.2 | 7.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 4.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 3.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 3.4 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 1.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 8.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 3.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 3.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 2.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 3.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 6.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 3.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 1.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 3.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 4.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 2.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.0 | 2.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 2.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 11.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 2.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 4.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 9.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 4.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.9 | 7.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 2.9 | 96.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 2.0 | 2.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.9 | 16.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 1.7 | 63.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 1.6 | 54.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 1.6 | 22.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.5 | 6.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.5 | 105.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 1.4 | 11.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.4 | 1.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 1.4 | 169.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.4 | 2.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 1.4 | 227.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 1.4 | 21.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 1.3 | 28.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 1.3 | 27.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 1.2 | 18.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 1.2 | 6.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 1.2 | 21.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 1.1 | 34.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 1.1 | 81.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 1.1 | 11.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 1.1 | 4.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 1.1 | 22.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 1.1 | 17.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.1 | 19.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 1.1 | 40.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 1.1 | 29.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 1.0 | 8.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 1.0 | 4.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 1.0 | 27.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 1.0 | 78.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 1.0 | 18.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.9 | 9.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.9 | 5.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.9 | 10.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.9 | 51.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.9 | 1.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.9 | 22.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.8 | 20.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.8 | 27.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.8 | 37.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.8 | 19.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.7 | 21.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.7 | 20.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.7 | 11.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.7 | 4.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.7 | 16.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.7 | 16.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.7 | 17.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.7 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.7 | 10.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.7 | 6.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.7 | 23.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.7 | 5.9 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.7 | 18.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.6 | 13.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.6 | 23.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.6 | 8.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.6 | 9.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.6 | 9.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.6 | 1.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.6 | 22.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.6 | 2.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.6 | 10.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.6 | 42.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.6 | 6.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.6 | 13.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.6 | 31.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.6 | 13.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.6 | 25.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.5 | 13.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.5 | 14.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.5 | 42.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.5 | 15.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.5 | 15.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.5 | 16.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.5 | 14.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.5 | 11.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.5 | 17.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.5 | 11.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.5 | 17.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.5 | 5.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.5 | 14.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.5 | 9.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.5 | 2.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.5 | 6.9 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.4 | 1.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.4 | 5.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.4 | 12.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.4 | 18.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.4 | 2.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.4 | 6.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.4 | 24.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.4 | 5.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.4 | 0.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.4 | 1.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.4 | 8.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.4 | 9.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.4 | 16.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.4 | 6.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.4 | 14.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.4 | 15.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.4 | 6.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.4 | 9.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.4 | 14.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 14.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.4 | 8.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.4 | 16.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.4 | 18.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.4 | 1.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.4 | 11.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.4 | 7.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.4 | 21.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.4 | 2.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.4 | 12.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
| 0.4 | 7.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.3 | 3.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.3 | 9.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.3 | 90.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.3 | 13.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.3 | 10.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.3 | 1.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
| 0.3 | 4.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.3 | 27.8 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
| 0.3 | 10.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 9.0 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.3 | 17.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.3 | 7.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.3 | 13.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.3 | 1.8 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.3 | 10.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.3 | 10.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.3 | 13.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.3 | 5.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 18.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 5.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.3 | 6.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 5.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.3 | 6.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.3 | 6.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.3 | 11.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.3 | 4.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.3 | 6.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 9.6 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
| 0.2 | 2.0 | REACTOME S PHASE | Genes involved in S Phase |
| 0.2 | 2.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 3.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 25.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.2 | 7.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.2 | 4.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 9.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.2 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.2 | 0.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 3.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 25.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.2 | 18.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 4.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.2 | 10.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 2.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 7.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 4.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.2 | 6.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 1.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.2 | 1.4 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
| 0.2 | 2.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.2 | 1.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 4.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 0.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 9.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 5.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 0.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 5.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 9.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.2 | 3.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 6.8 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.2 | 8.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 3.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 1.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.2 | 30.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.2 | 3.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.2 | 6.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 4.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 11.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.1 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 7.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 52.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.1 | 3.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.1 | 9.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 5.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 2.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 1.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.1 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 1.5 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
| 0.1 | 1.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 2.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.1 | 1.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 3.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.1 | 1.5 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.0 | 6.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.0 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.0 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.0 | 2.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 6.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 2.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
| 0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |